Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▼ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Salarius Pharmaceuticals Inc. | 0 | 1 | 0 | 0 | €0.39 | - | - |
| Coherus Bioscien. | 0 | 2 | 0 | 0 | €1.25 | - | - |
| Gritstone Oncology Inc | 6 | 1 | 2 | 0 | €0.43 | €3.68 | 747.924% |
| Atara Biotherapeutics Inc. | 2 | 2 | 0 | 0 | €0.37 | €3.00 | 716.549% |
| Karyopharm Therapeutics Inc. | 8 | 1 | 3 | 0 | €0.69 | €5.49 | 691.580% |
| Minerva Neurosciences Inc. | 0 | 10 | 0 | 1 | €2.50 | - | - |
| Organovo Holdings Inc. | 0 | 9 | 0 | 1 | €0.54 | - | - |
| Promis Neurosciences Inc. | 0 | 1 | 0 | 0 | €1.08 | €1.20 | 11.111% |
| Trevena Inc. | 2 | 23 | 0 | 3 | €0.15 | €6.48 | 4136.601% |
| Biofrontera AG | 0 | 1 | 0 | 0 | €0.33 | - | - |
| T2 Biosystems Inc. | 0 | 4 | 0 | 0 | €0.16 | - | - |
| Fate Therapeutics Inc. | 3 | 3 | 0 | 0 | €3.22 | €7.31 | 127.384% |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.12 | - | - |
| Medigene AG | 1 | 1 | 0 | 0 | €1.06 | - | - |
| Viking Therapeutics Inc | 4 | 1 | 0 | 1 | €58.02 | - | - |
| Protalix Biotherapeutics Inc. | 1 | 1 | 0 | 0 | €0.85 | €2.00 | 135.183% |
| Enzo Biochem. Inc. | 0 | 1 | 0 | 0 | €1.00 | - | - |
| Natural Alternat. | 19 | 1 | 0 | 0 | €4.74 | - | - |
| Pacific Biosciences of California Inc. | 10 | 4 | 1 | 0 | €1.24 | €9.20 | 639.228% |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | €0.34 | €21.06 | 6072.333% |
| Edap Tms S.A. ADR | 5 | 1 | 1 | 0 | €2.80 | €17.46 | 523.607% |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €36.20 | €50.00 | 38.122% |
| Nevro Corp. | 1 | 4 | 0 | 1 | €5.60 | €13.77 | 145.909% |
| Rocket Pharmaceuticals Inc | 2 | 1 | 0 | 0 | ? | €32.00 | 87.849% |
| Enlivex Therapeutics Ltd. | 0 | 1 | 0 | 0 | €1.11 | - | - |